×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LEGN – legend biotech corporation - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LEGN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
09:06 am
legn
Legend Biotech (NASDAQ:LEGN) was given a new $74.00 price target on by analysts at Cantor Fitzgerald.
Low
Report
Legend Biotech (NASDAQ:LEGN) was given a new $74.00 price target on by analysts at Cantor Fitzgerald.
12/17
08:43 am
legn
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/17
08:00 am
legn
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/12
12:00 pm
legn
Legend Biotech (NASDAQ:LEGN) was given a new $50.00 price target on by analysts at Morgan Stanley.
Low
Report
Legend Biotech (NASDAQ:LEGN) was given a new $50.00 price target on by analysts at Morgan Stanley.
12/11
05:31 pm
legn
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
Medium
Report
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
12/11
05:31 pm
legn
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
Medium
Report
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
12/11
11:48 am
legn
Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects [Yahoo! Finance]
Low
Report
Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects [Yahoo! Finance]
12/9
04:25 pm
legn
Legend Biotech (NASDAQ:LEGN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Legend Biotech (NASDAQ:LEGN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/8
07:30 am
legn
Form 6-K Legend Biotech Corp For: Dec 08
Medium
Report
Form 6-K Legend Biotech Corp For: Dec 08
11/17
05:50 pm
legn
Form 144 Legend Biotech Corp Filed by: GenScript Corp
Low
Report
Form 144 Legend Biotech Corp Filed by: GenScript Corp
11/12
07:01 am
legn
Form 6-K Legend Biotech Corp For: Sep 30
Low
Report
Form 6-K Legend Biotech Corp For: Sep 30
11/5
11:41 am
legn
Form SCHEDULE 13G/A Legend Biotech Corp Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Legend Biotech Corp Filed by: FMR LLC
11/3
04:01 pm
legn
Form 6-K Legend Biotech Corp For: Nov 03
Low
Report
Form 6-K Legend Biotech Corp For: Nov 03
10/14
08:00 am
legn
Form 6-K Legend Biotech Corp For: Oct 10
Low
Report
Form 6-K Legend Biotech Corp For: Oct 10
10/14
07:31 am
legn
Form 6-K Legend Biotech Corp For: Oct 14
Medium
Report
Form 6-K Legend Biotech Corp For: Oct 14
10/7
04:02 pm
legn
Form 6-K Legend Biotech Corp For: Oct 07
Low
Report
Form 6-K Legend Biotech Corp For: Oct 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: